Biogen Pharmachem Financials

BSE: 531752

₹0.27

₹0.00 (0.00%)

As on 11-Sep-2026 13:46IST

Market cap

₹28 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	1.02	--	--	--	2.47	1.62
Total Income	1.46	1.20	2.38	0.91	2.48	1.62
Total Expenditure	1.62	1.47	0.45	0.46	2.49	3.23
EBITDA	-0.60	-1.47	-0.45	-0.46	-0.02	-1.60
Depreciation	--	--	--	--	--	--
EBIT	-0.60	-1.47	-0.45	-0.46	-0.02	-1.60
Interest	--	--	--	0.00	0.00	0.00
Other Income	0.44	1.20	2.38	0.91	0.01	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.17	-0.27	1.93	0.46	-0.01	-1.60
Provision for Tax	--	0.02	--	--	--	--
Profit after Tax	-0.17	-0.29	1.93	0.46	-0.01	-1.60

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	99.09	91.93	56.52	54.59	54.13	54.14
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.10	--	--	--	--	--
Current Liabilities	0.21	0.09	0.30	0.24	0.82	0.11
Total Liabilities	99.40	92.02	56.82	54.83	54.95	54.25

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	98.91	89.35	56.73	54.67	53.02	51.69
Current Assets	0.49	2.67	0.09	0.15	1.93	2.56
Total Assets	99.40	92.02	56.82	54.83	54.95	54.25
Total Debt*	--	--	--	--	--	--
Net Current Assets	0.27	2.58	-0.21	-0.08	1.12	2.45
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-1.08	1.94	1.70	1.40	3.95
Cash Flow from Investing Activities	--	-32.62	-2.06	-1.66	-1.32	-3.64
Cash from Financing Activities	--	35.70	--	--	--	-0.31
Net Cash Inflow / Outflow	--	2.00	-0.11	0.05	0.08	0.00

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	0.00	0.00	0.03	0.01	0.00	-0.02
Cash EPS (₹)	0.00	0.00	0.03	0.01	0.00	-0.02
Adjusted Book Value (₹)	1.09	0.74	0.74	0.72	0.71	0.71
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.02	0.03	0.03	0.02	0.06
Free Cash Flow per Share (₹)	--	-0.02	0.03	0.03	0.02	0.06

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-0.36	3.48	0.84	-0.02	-2.91
ROE (%)	-0.17	-0.52	3.48	0.84	-0.02	-2.92
ROA (%)	-0.17	-0.39	3.46	0.83	-0.02	-2.91
EBIT Margin (%)	-59.06	--	--	--	-0.61	-98.80
Net Margin (%)	-11.39	-24.44	81.07	49.90	-0.35	-98.81
Cash Profit Margin (%)	--	--	--	--	-0.35	-98.81

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-64.73	--	--	-100.00	52.48	--
EBIT Growth (%)	-136.88	-225.55	1.40	-2,907.89	99.05	-1,273.79
Net Profit Growth (%)	-64.73	-115.16	323.86	5,396.51	99.46	-1,273.83
EPS Growth (%)	-114.41	-115.20	322.86	7,100.00	99.59	-1,275.70
Book Value Growth (%)	--	-0.52	3.54	0.84	-0.02	-2.88

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-123.40	--	35.81	84.29	--	--
Price / Book Value	0.25	1.11	1.22	0.71	1.69	0.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-169.34	-224.65	35.82	84.23	--	-8.54
Close Price (₹)	0.31	0.82	0.91	0.51	1.20	0.18
High Price (₹)	0.93	1.51	1.59	1.41	1.59	0.32
Low Price (₹)	0.30	0.79	0.46	0.45	0.17	0.16
Market Cap (₹ Cr)	28.43	--	--	--	91.36	13.70

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	2.28	29.65	0.30	0.65	2.37	23.64
Quick Ratio	2.28	29.65	0.30	0.65	2.37	23.64
Interest Coverage	--	--	--	4,556.00	-42.00	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	--	--	--	--	--	156.56
Asset Turnover	0.01	--	--	--	0.05	0.03
Receivable days	--	--	--	--	--	1,188.42
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	15.00
Cash Conversion Cycle	--	--	--	--	--	1,173.42

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.